Solvay reported second-quarter 2026 underlying net sales of €1,031 million, down 7.4% organically from a year earlier, and confirmed its full-year guidance. Underlying EBITDA fell 19.5% organically to €187 million, with the margin narrowing to 18.1%, as the company cited continued weakness in soda ash pricing and a negative impact from the Middle East conflict that temporarily shut its Peroxides plant in the region. Structural cost savings delivered another €26 million in the quarter, and underlying net profit from continuing operations was €64 million. Free cash flow for the first half was €15 million, with underlying net debt at €1.8 billion and a leverage ratio of 2.3 times. Solvay expects a stronger second half, anticipating the restart of its Saudi Arabia Peroxides plant in the third quarter, and reaffirmed its 2026 outlook for underlying EBITDA between €770 million and €850 million and free cash flow of at least €200 million.
Solvay SAQ2 earnings declined with underlying EBITDA down 19.5% and margin narrowing to 18.1%.